SCHEMBL10302255

SCHEMBL10302255

CCOCc1ccc(-c2ccc(COc3ccc(C)c(F)c3F)cc2)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRG P48443 4/20 0.41
RXRA P19793 3/20 0.41
RXRB P28702 3/20 0.41
MRGPRX4 Q96LA9 2/20 0.38
FFAR4 Q5NUL3 2/20 0.38
FFAR1 O14842 4/20 0.35
PPARD Q03181 3/20 0.35
FEN1 P39748 1/20 0.34
ABCB1 P08183 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
CNR1 P21554 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
PPARA Q07869 1/20 0.32
HDAC1 Q13547 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10302232 0.90 FFAR4 (0.39) RXRGRXRARXRBMRGPRX4FFAR4
SCHEMBL12736578 0.89 FFAR4 (0.44) RXRGRXRARXRBMRGPRX4FFAR4
SCHEMBL13654151 0.89 MRGPRX4 (0.45) MRGPRX4FFAR4FFAR1ABCB1LMNA
SCHEMBL10303125 0.87 FFAR4 (0.37) RXRGRXRARXRBMRGPRX4FFAR4
SCHEMBL12716908 0.87 ABCB1 (0.41) RXRGRXRARXRBMRGPRX4FFAR4
SCHEMBL10302248 0.85 FFAR1 (0.46) FFAR4FFAR1PPARDS1PR1S1PR3
SCHEMBL13586105 0.85 FFAR1 (0.42) MRGPRX4FFAR1PPARDPPARA
SCHEMBL12741036 0.83 FFAR4 (0.45) RXRGRXRARXRBMRGPRX4FFAR4
SCHEMBL10302204 0.83 FFAR4 (0.35) RXRGRXRARXRBMRGPRX4FFAR4
SCHEMBL10302230 0.83 RXRG (0.40) RXRGRXRARXRBMRGPRX4FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8216489-B2 Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-07-10 US disclosed
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE LEF1, LAS1L, L3MBTL3 RXRG 3228/4885RXRA 2617/4885RXRB 3102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.